Tomoya Watanabe

750 total citations
46 papers, 467 citations indexed

About

Tomoya Watanabe is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Tomoya Watanabe has authored 46 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 9 papers in Dermatology. Recurrent topics in Tomoya Watanabe's work include Drug-Induced Adverse Reactions (8 papers), Systemic Sclerosis and Related Diseases (8 papers) and Urticaria and Related Conditions (5 papers). Tomoya Watanabe is often cited by papers focused on Drug-Induced Adverse Reactions (8 papers), Systemic Sclerosis and Related Diseases (8 papers) and Urticaria and Related Conditions (5 papers). Tomoya Watanabe collaborates with scholars based in Japan, United States and United Kingdom. Tomoya Watanabe's co-authors include Yukie Yamaguchi, Michiko Aihara, Yuko Watanabe, Carol Feghali‐Bostwick, Noriko Komitsu, Tsukasa Seya, Misako Matsumoto, Jonathan Heywood, Kotaro Fukuda and Tsunemi Hasegawa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Tomoya Watanabe

43 papers receiving 459 citations

Peers

Tomoya Watanabe
Jürgen Beer Switzerland
M. Price United Kingdom
Kevin Tse United States
Margaret H. Terhune United States
Yousef Binamer Saudi Arabia
Jürgen Beer Switzerland
Tomoya Watanabe
Citations per year, relative to Tomoya Watanabe Tomoya Watanabe (= 1×) peers Jürgen Beer

Countries citing papers authored by Tomoya Watanabe

Since Specialization
Citations

This map shows the geographic impact of Tomoya Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoya Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoya Watanabe more than expected).

Fields of papers citing papers by Tomoya Watanabe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoya Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoya Watanabe. The network helps show where Tomoya Watanabe may publish in the future.

Co-authorship network of co-authors of Tomoya Watanabe

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoya Watanabe. A scholar is included among the top collaborators of Tomoya Watanabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoya Watanabe. Tomoya Watanabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nagasawa, Yutaka, Kaoru Takase-Minegishi, Tomoya Watanabe, et al.. (2025). Successful re-administration of tocilizumab in a patient with adult-onset Still’s disease after improvement of macrophage activation syndrome. Modern Rheumatology Case Reports. 9(2).
4.
Takamura, Naoko, et al.. (2024). A water-soluble caveolin-1 peptide inhibits psoriasis-like skin inflammation by suppressing cytokine production and angiogenesis. Scientific Reports. 14(1). 20553–20553. 2 indexed citations
5.
Watanabe, Tomoya, et al.. (2024). Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients. Arthritis Research & Therapy. 26(1). 93–93. 5 indexed citations
6.
Watanabe, Tomoya, et al.. (2023). Post‐orgasmic illness syndrome with positive intradermal test for autologous semen. The Journal of Dermatology. 50(7). 951–955. 4 indexed citations
7.
Watanabe, Tomoya & Yukie Yamaguchi. (2023). Cutaneous manifestations associated with immune checkpoint inhibitors. Frontiers in Immunology. 14. 1071983–1071983. 54 indexed citations
8.
Ikeda, Noriko, et al.. (2023). Periostin—An inducer of pro-fibrotic phenotype in monocytes and monocyte-derived macrophages in systemic sclerosis. PLoS ONE. 18(8). e0281881–e0281881. 3 indexed citations
9.
Watanabe, Tomoya, Yuko Watanabe, Noriko Ikeda, Michiko Aihara, & Yukie Yamaguchi. (2022). Serum levels of C‐C motif chemokine ligand 2 and interleukin‐8 as possible biomarkers in patients with toxic epidermal necrolysis accompanied by acute respiratory distress syndrome. The Journal of Dermatology. 50(4). 500–510. 2 indexed citations
10.
Watanabe, Tomoya, et al.. (2022). Risks of malignancies among patients with psoriasis: A cohort study of 360 patients. The Journal of Dermatology. 50(5). 615–621. 6 indexed citations
11.
Watanabe, Tomoya, Naoko Takamura, Yuko Watanabe, et al.. (2021). A pediatric case of Stevens‐Johnson syndrome with acute liver failure, resulting in liver transplantation. The Journal of Dermatology. 48(9). 1423–1427. 3 indexed citations
12.
Yamaguchi, Yukie, Noriko Komitsu, Tomoya Watanabe, et al.. (2021). Downregulated IRF8 in Monocytes and Macrophages of Patients with Systemic Sclerosis May Aggravate the Fibrotic Phenotype. Journal of Investigative Dermatology. 141(8). 1954–1963. 23 indexed citations
13.
Watanabe, Tomoya, et al.. (2021). E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects. JCI Insight. 6(24). 16 indexed citations
14.
Watanabe, Yuko, Saki Takahashi, Tomoya Watanabe, et al.. (2020). A case of toxic epidermal necrolysis associated with apalutamide administration. Journal of Cutaneous Immunology and Allergy. 3(6). 134–135. 14 indexed citations
15.
Watanabe, Tomoya, Yukie Yamaguchi, Yuko Watanabe, Naoko Takamura, & Michiko Aihara. (2020). Increased level of high mobility group box 1 in the serum and skin in patients with generalized pustular psoriasis. The Journal of Dermatology. 47(9). 1033–1036. 13 indexed citations
16.
Cox, Cathy R., et al.. (2020). Attenuating Pain With the Past: Nostalgia Reduces Physical Pain. Frontiers in Psychology. 11. 572881–572881. 7 indexed citations
17.
Watanabe, Tomoya, Yusuke Saigusa, Naoko Takamura, et al.. (2020). Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients. Allergology International. 70(2). 229–234. 21 indexed citations
18.
Yamaguchi, Yukie, Yuko Watanabe, Tomoya Watanabe, Noriko Komitsu, & Michiko Aihara. (2015). Decreased Expression of Caveolin-1 Contributes to the Pathogenesis of Psoriasiform Dermatitis in Mice. Journal of Investigative Dermatology. 135(11). 2764–2774. 27 indexed citations
19.
Watanabe, Tomoya, Kiyoharu Ito, Misako Matsumoto, et al.. (2009). ISOLATION AND CHARACTERIZATION OF RNA APTAMERS SPECIFIC FOR THE HUMAN TOLL-LIKE RECEPTOR 3 ECTODOMAIN. 37(1). 10–18. 1 indexed citations
20.
Watanabe, Tomoya, Kiyoharu Ito, Misako Matsumoto, et al.. (2006). Isolation of RNA aptamers against human Toll-like receptor 3 ectodomain. Nucleic Acids Symposium Series. 50(1). 251–252. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026